Treatment differences compared to the 2015 study were noted with 21% now being prescribed GLP-1 analogs. A recent meta-analysis showed they are associated with substantial reductions in HbA1c, and weight in youth with type 2 diabetes and NICE guidance suggests these agents should be considered [24]. Here, GCG is linked to type 2 diabetes mellitus.